Citation Tools

Download PDFPDF
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis

Download to a citation manager

Cite this article as:
Maini RN, Taylor PC, Paleolog E, et al
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis